Sunday, June 20, 2021 8:11:22 PM
Might he have a reason to lie?
IDK man, just seems like another way to find out is to match his forum handles to the article; notice the timestamps and how he presents the article, you could then check the profile to see that he has a history of linking his own articles and making comments as if he's a passive observer. Specifically the comment attached to this article was "Amazing article about the covid 19 market".
I've made up my mind, and I don't care what he says in emails; he has reason to lie, and there's a reason the disclosure says nothing about the authors position.
I'd be more shocked if he stated he was invested through email, which could potentially hurt him monetarily.
For myself; if you want me to believe something - show me the data. I'm not swayed by what people say, people lie. Data and behavior is more telling.
Especially considering he changed the title after. It showcases exactly where his priorities are - with promoting Todos.
That's great, but I'm not going to pretend he doesn't have his own motives. I love that the article is bringing in investor eyes, but I'm not going to ignore patterns, which BTW; I had no idea he changed title until you brought it up. I saw it at about 3 in the morning on June 19th when it was originally posted.
Alliance Creative Group (ACGX) Releases Q2 2024 Financial and Disclosure Report with an increase of over $130,000 in Net Income from Q2 2023 to Q2 2024 • ACGX • Aug 14, 2024 8:30 AM
Avant Technologies Unveils AI-Powered Healthcare Infrastructure to Deliver Intelligent Healthcare Solutions • AVAI • Aug 14, 2024 8:00 AM
SANUWAVE Announces Record Quarterly Revenues: Q2 FY2024 Financial Results • SNWV • Aug 13, 2024 7:11 AM
Kona Gold Beverages, Inc. Nears Completion of Reverse Merger with New Candidate • KGKG • Aug 12, 2024 10:00 AM
Maybacks Global Entertainment and DigiTrax Entertainment Sign Agreement to Broadcast "Karaoke Cloud" on iDreamCTV • AHRO • Aug 12, 2024 8:45 AM
HealthLynked Partners with RxSpark to Enhance Medication Access and Management for Patients • HLYK • Aug 12, 2024 8:00 AM